CBRE vs CCEL · P/E 43, rev $35.77B vs P/E 490, $39.6M cap
CBRE Group Inc Class A (CBRE) versus CryoCell International Inc (CCEL) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
CCEL does not have a complete income-statement cache yet.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. CCEL currently screens at market cap $39.6M and trailing P/E 490.0.
Not investment advice. Open the CBRE and CCEL stock pages for the full models.
Not investment advice.